Mucuna Pruriens Vega Caps 400mg (125 pieces)

Brief Intro

Mucuna Pruriens Vega Caps 400mg (125 pieces) contain a high-quality extract of Mucuna pruriens, a tropical legume also known as velvet bean. This plant is valued for its rich content of L-DOPA, a direct precursor to dopamine, which supports mood, motivation, cognitive function, and neurological health. Traditionally used in Ayurvedic medicine, Mucuna pruriens exhibits antioxidant, neuroprotective, and adaptogenic properties. The product is intended strictly for research or supplemental use and is not for human consumption.

Chemical Composition / Physical Properties

• Active Ingredient: Mucuna pruriens seed extract standardized to contain L-DOPA

• Dosage per Capsule: 400 mg

• Quantity: 125 vegetarian capsules per bottle

• Appearance: White to off-white powder encapsulated in vegetarian capsules

• Storage: Store in a cool, dry place, protected from light and moisture

Pharmacology and Mechanism of Action

Mucuna pruriens seeds contain approximately 5% L-DOPA along with diverse phytochemicals including alkaloids (mucunadine, mucunine), amino acids (phenylalanine, tyrosine, tryptophan), saponins, tannins, and antioxidants. L-DOPA from Mucuna pruriens crosses the blood-brain barrier and is converted into dopamine, a key neurotransmitter involved in mood regulation, motivation, libido, and motor control. This natural dopamine precursor supports cognitive function, reduces symptoms of depression, and may improve motor function in neurodegenerative conditions such as Parkinson’s disease. Additionally, Mucuna pruriens exhibits antioxidant and anti-inflammatory effects that contribute to neuroprotection.

Intended Use

Mucuna Pruriens Vega Caps 400mg are intended strictly for laboratory research, nutritional supplementation, and studies on dopamine-related neurological and psychological functions. They are not intended for human or veterinary consumption without proper authorization.

Dosage and Usage

• Suggested nootropic dosage ranges from 250 mg to 500 mg twice daily, adjusted according to L-DOPA content and individual response.

• Due to dopamine receptor sensitivity and tolerance development, cycling use (e.g., 4–5 days on, 2–3 days off) is recommended to avoid tolerance and dependence.

• For Parkinson’s disease research, higher doses (500–1,000 mg three or more times daily) of standardized extract may be used.

• Capsules should be taken with water, preferably with food to enhance absorption and reduce gastrointestinal discomfort.

Safety and Side Effects

L-DOPA from Mucuna pruriens is generally well tolerated and may cause fewer side effects than synthetic L-DOPA formulations. Possible adverse effects include:

• Nausea

• Headache

• Insomnia

• Dyskinesia (at high doses)

• Rarely, hallucinations or psychosis with excessive dopamine levels

• Hair loss (rare)

Careful dosing and monitoring are advised, especially in individuals sensitive to dopamine or those on dopaminergic medications. Avoid combining with other L-DOPA sources or dopamine agonists without supervision.

Legal & Compliance Disclaimer

All products are sold for research or supplemental purposes only and are not intended for human consumption or medical treatment without professional guidance. Customers must verify the legal status of Mucuna pruriens and L-DOPA in their jurisdiction before ordering. The vendor reserves the right to accept or decline orders based on intended use.